Dublin, March 20, 2018 -- The "Global Hospital Care Partnering 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.
Global Hospital Care Partnering 2012 to 2018 provides the full collection of Hospital Care disease deals signed between the world's pharmaceutical and biotechnology companies since 2012.
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Hospital Care disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Hospital Care deals.
The report presents financial deal terms values for Hospital Care deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
In addition, a comprehensive appendix is provided with each report of all Hospital Care partnering deals signed and announced since 2012. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Report scope
Global Hospital Care Partnering 2012 to 2018 includes:
- Trends in Hospital Care dealmaking in the biopharma industry since 2012
- Analysis of Hospital Care deal structure
- Access to headline, upfront, milestone and royalty data
- Access to hundreds of Hospital Care deal contract documents
- Comprehensive access to over 3500 Hospital Care deal records
- The leading Hospital Care deals by value since 2012
- Most active Hospital Care dealmakers since 2012
Available deals and contracts are listed by:
- Headline value
- Upfront payment value
- Royalty rate value
- Stage of development at signing
- Deal component type
- Technology type
- Specific therapy indication
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in Hospital Care dealmaking
2.1. Introduction
2.2. Hospital Care partnering over the years
2.3. Hospital Care partnering by deal type
2.4. Hospital Care partnering by industry sector
2.5. Hospital Care partnering by stage of development
2.6. Hospital Care partnering by technology type
2.7. Hospital Care partnering by therapeutic indication
Chapter 3 - Financial deal terms for Hospital Care partnering
3.1. Introduction
3.2. Disclosed financials terms for Hospital Care partnering
3.3. Hospital Care partnering headline values
3.4. Hospital Care deal upfront payments
3.5. Hospital Care deal milestone payments
3.6. Hospital Care royalty rates
Chapter 4 - Leading Hospital Care deals and dealmakers
4.1. Introduction
4.2. Most active in Hospital Care partnering
4.3. List of most active dealmakers in Hospital Care
4.4. Top Hospital Care deals by value
Chapter 5 - Hospital Care contract document directory
5.1. Introduction
5.2. Hospital Care partnering deals where contract document available
Chapter 6 - Hospital Care dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Hospital Care therapeutic target
For more information about this report visit https://www.researchandmarkets.com/research/stkvgj/global_hospital?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hospital Management


Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Jetstar to Charge for Overhead Cabin Bags From February
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management 



